International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 14 , ISSUE S2 ( Special Issue (Behaviour Management), 2021 ) > List of Articles

RESEARCH ARTICLE

Intranasal Midazolam Premedication for Anxiolysis in Children Reluctant to Receive Nitrous Oxide Sedation via Nasal Hood: An In Vivo Randomized Control Trial

Iqbal Musani, Sabina Bhure, Shikha Choubey, Smita Iqbal Musani, Safa Surve

Keywords : Behavior management, Conscious sedation, Dental anxiety, Midazolam, Premedication

Citation Information :

DOI: 10.5005/jp-journals-10005-2092

License: CC BY-NC 4.0

Published Online: 01-02-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Aim and objective: The aim of the study was to compare administration of 0.1 mg/kg intranasal midazolam as premedication against a normal saline control in alleviating anxiety relating to and increasing acceptance of nasal hood by child patients receiving nitrous oxide sedation. Materials and methods: After ethical clearance and informed consent, on the basis of odd and even numbers patients were allocated to group midazolam (group M) or group normal saline (group N), respectively. The physical parameters were recorded at the beginning and after the procedure; time required for the procedure was also recorded. The level of cooperation during acceptance of the nasal mask by the patient was evaluated using the four-point scale. Result: Group M (midazolam premedication) was more effective in improving the acceptance of the nasal hood in children than the normal saline/traditional/conventional method of treating the teeth. The p-value is .002308. Conclusion: In the present study the combination of midazolam and nitrous oxide proved to be an effective combination, resulting in good to excellent behavior in children who were Frankl's behavior rating definitely negative and negative. Clinical significance: For successful sedation premedication with nitrous oxide, midazolam is an excellent premedication drug.


PDF Share
  1. Koch G, Paulsen S. Pediatric dentistry a clinical approach 1st ed. Copenhagen: Munksgaard; 2001. pp. 53–54.
  2. Shashikiran ND, Reddy SV, Yavagal CM. Conscious sedation - an artist's science! An Indian experience with midazolam. J Indian Soc Pedod Prev Dent 2006;24(1):7–14. DOI: 10.4103/0970-4388.22830
  3. Finn SB. Clinical Pedodontics 4th ed. USA: W.B Saunders; 2003. pp. 18–20.
  4. Mc Donald RE, Avery DR, Dean JA. Dentistry for the child and adolescent 8th ed. Missouri: Mosby Elsevier; 2004. pp. 35–36.
  5. Yasny JS, Asgari A. Consideration for the usage of enteral sedation in pediatric dentistry. J Clin Pediatr Dent 2007;32:85–93. DOI: 10.17796/jcpd.32.2.20777386241103x8
  6. Dean JA Avery DR, Ralph E. McDonald: dentistry for the child and adolescent 9th edition 2011, 253–61.
  7. Korttila K, Saarnivaara L, Tarkkanen J, et al. Comparison of diazepam and flunitrazepam for sedation during local anaesthesia for bronchoscopy. Br J Anaesth 1978; 50(3): 281–287. DOI: 10.1093/bja/50.3.281
  8. Koppal R, Ambi U, Anilkumar G. Comparison of the Midazolam tranasal atomizer and oral midazolam for sedative pre-medication in pediatric cases. J Clin Diagn 2011; 5(5):932–934.
  9. Al-Zahrani AM, Wyne AH, Sheta SA. Comparison of oral midazolam with a combination of oral midazolam and nitrous oxide - oxygen inhalation in the effectiveness of dental sedation for young children. J Indian Soc Pedod Prev Dent 2009;27:9–16. DOI: 10.4103/0970-4388.50810
  10. Choksi AA, Patel VR, Chauhan PR, et al. Evaluation of intra-nasal midazolam spray as a sedative in pediatric patients for radiological imaging procedures. Anesth Essays Res. 2013, 7, 2, 189-193. DOI: 10.4103/0259-1162.118954
  11. Roelofse JA, Shipton EA, deLa Harpe CJ, et al. Intranasal sufentanil/ mdazolam/ sedation in the pediatric population prior to undergoing multiple dental extractions under genaeral anesthesia: a prospective, double-blind, randomized comparison. Anesth Prog 2004; 51:114–121.
  12. Illum, L. Transport of drugs from nasal cavity to the central nervous system. Eur J Pharm Sci 2000;11:1–18. DOI: 10.1016/s0928-0987(00)00087-7
  13. Paterson S, Tahmassebi JF. Paediatric dentistry in the new millennium: 3 Use of inhalation sedation in paediatric dentistry. Dent Update 30(7):350–356. DOI: 10.12968/denu.2003.30.7.350
  14. ASA physical status classification system. American Society of Anesthesiologists. Archived from the original on 2017-12-4.
  15. Wood M, The safety and efficacy of intranasal midazolam sedation combined with inhalation sedation with nitrous oxide and oxygen in paediatric dental patients as an alternative to general anaesthesia. SAAD Dig 2010;26:12–22.
  16. Al-Rakaf H, Bello LL, Turkustani A. Intranasal midazolam in conscious sedation of young pediatric dental patients. Int J Pediatr Dent 2001;11: 33–40. DOI: 10.1046/j.1365-263x.2001.00237.x
  17. Musani1 IE, Chandan NV. A comparison of the sedative effect of oral versus nasal midazolam combined with nitrous oxide in uncooperative children. Int J Clin Pediatr Dent 2009; 2(3): 15–22. DOI: 10.1007/s40368-015-0187-7
  18. Wilson KE, Girdler NM, Welbury RR. Randomized, controlled, cross-over clinical trial comparing the intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions. Brit Dent J Anaesth, 2003. DOI: 10.1093/bja/aeg278
  19. Pedersen RS, Bayat A, Steen NP, et al. Nitrous oxide provides safe and effective analgesia for minor paediatric procedures–a systematic review. Danish Med J 2013; 60(6):A4627.
  20. Dock M, Creedon RL. Pharmacological management of patient behavior. McDonald RE, Avery DR. Dentistry for the Children and Adolescent 8th ed. St. Louis, CV Mosby 2004: 285–311.
  21. Jackson DL, Johnson BS. Conscious sedation for dentistry: risk management and patient selection. Dent Clin 2002;46(4):767–780. DOI: 10.1016/s0011-8532(02)00034-4
  22. Sievers TD, Yee JD, Foley ME, et al. Midazolam for conscious sedation during pediatric oncology procedures: safety and recovery parameters. Pediatrics 1991; 88(6):1172–1179.
  23. Primosch RE, Guelmann M. Comparison of drops versus spray administration of intranasal midazolam in two-and three-year-old children for dental sedation. Pediatr Dent 2005; 27(5):401–408.
  24. Hussain AA. Mechanism of nasal absorption of drugs. Prog Clin Biol Res 1988; 292:261.
  25. Wilton NC, Leigh J, Rosen DR, et al. Preanesthetic sedation of preschool children using intranasal midazolam. J Am Soc Anesthesiol 1988; 69(6):972–974. DOI: 10.1097/00000542-198812000-00032
  26. Davies FC, Waters M. Oral midazolam for conscious sedation of children during minor procedures. J Accid Emerg Med 1998; 15(4):244–248.
  27. Damle SG, Gandhi M, Laheri V. Comparison of oral ketamine and oral midazolam as sedative agents in pediatric dentistry. J Indian Soc Pedod Prev Dent 2008;26: 97–101. DOI: 10.4103/0970-4388.43186
  28. Patel V, Singh N, Saksena AK, et al. A comparative assessment of intranasal and oral dexmedetomidine for procedural sedation in pediatric dental patients. J Indian Soc Pedod Prev Dent 2018;36:370–375. DOI: 10.4103/jisppd.jisppd_40_18
  29. Pitetti RD, Singh S, Pierce MC. Safe and efficacious use of procedural sedation and analgesia by nonanesthesiologists in a pediatric emergency department. Arch Pediatr Adolesc Med 2003;157:1090–1096. DOI: 10.1001/archpedi.157.11.1090
  30. Boyle CA, Newton T, Milgrom P. Who is referred for sedation for dentistry and why? Br Dent J 2009;206:E12. DOI: 10.1038/sj.bdj.2009.251
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.